Infarct size-limiting effect of calcium preconditioning in rabbit hearts. by Kim, Ho-dirk
INTRODUCTION
A brief period of ischemia followed by reperfusion (ischemic
preconditioning, IPC) can attenuate lethal injury to the heart
as a result of prolonged period of ischemia and/or reperfusion
(1-3). IPC has been shown to limit infarct size in ischemic
myocardium to a remarkable degree in a variety of laborato-
ry animals (4-9). Recent evidences suggest that this power-
ful endogenous cellular adaptation is conserved in a human
heart (10). Activation of adenosine A1 (11),  1 adrenergic (12),
bradykinin B2 receptors (13), opening of KATP channels (14),
preservation of myocardial high-energy phosphate (15), and
attenuation of ischemia-induced acidosis (16) have been pro-
posed as responsible mechanisms of IPC, but the exact mech-
anisms still remain inconclusive.
Ashraf et al. (17) have demonstrated that repetitive Ca2+
depletion and repletion for short duration (Ca2+ precondition-
ing, CPC) can protect the heart against ischemia/reperfusion
injury via the activation of protein kinase C (PKC) in a rat
heart. It has been well documented that the activation of PKC
plays an important role in IPC-induced cardioprotection against
the development of myocardial infarction and post-ische-
mic contractile dysfunction (3, 18, 19). However, the rela-
tionship between CPC and PKC and/or PKC isozymes in a
rabbit heart remains unclear. In this respect, this study was
performed to determine whether CPC is cardioprotective as
IPC, and to assess whether PKCs are involved in Ca2+-mediat-
ed preconditioning in rabbit hearts, if CPC is cardioprotective.
MATERIALS AND METHODS
Preparation of the heart
This study followed guidelines for the use of laboratory
animals from the American Physiological Society. Male New
Zealand White rabbits weighing 1.5 to 2.0 kg were used.
They were fed ad libitum with balanced diet and water, and
housed in an acclimated room throughout the experiments.
The animal was stunned by a blow to the neck 30 min after
intraperitoneal heparinization (300 IU/kg). The heart was
rapidly isolated, transferred to a Langendorff perfusion appa-
ratus (size 5, Hugo Sachs Elektronik, March-Hugstetten, Ger-
many), and perfused with a constant flow rate (30 mL/min)
of oxygenated Tyrode solution (containing in mmol/L: NaCl
140, KCl 4.4, CaCl2 1.0, MgCl2 1.0, HEPES buffer 3.0, and
glucose 10.0) at 37 . The pH of the perfusate was equili-
brated a physiological range (7.3-7.4). A latex balloon connect-
ed to a pressure transducer was inserted into the left ventri-
cular cavity through the mitral opening. Eight to 10 mmHg
of the initial left ventricular end-diastolic pressure (LVEDP)
was loaded, and the heart was constantly paced at 150 beats/
min with an electrical stimulator (Harvard Apparatus, Eden-
bridge, U.K.). Hemodynamic parameters including left ven-
tricular developed pressure (LVDP) and differentiation of the
left ventricular pressure were monitored throughout the experi-
ment as previously described (5).
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Recent studies demonstrated that brief period of Ca
2+ depletion and repletion (Ca
2+
preconditioning, CPC) has strong protective effects against ischemia in a rat heart.
CPC and classic preconditioning (IPC) were compared in relation with infarct size
and protein kinase C (PKC) isozymes. Isolated Langendorff-perfused rabbit hearts
were subjected to 45-min ischemia (Isc) followed by 120-min reperfusion (R) with
or without IPC, induced by 5-min Isc and 10-min R. In the CPC hearts, 5-min Ca
2+
depletion and 10-min repletion (CPC) were given before 45-min Isc, with or with-
out concurrent PKC inhibition (calphostin C, 200 nmol/L). IPC enhanced recovery
of LV function, while CPC did not. Infarct size was significantly reduced by both
CPC and IPC (p<0.05 vs. ischemic control). Membrane PKC was significantly in-
creased from 2.53 0.07 (baseline, nmol/g tissue) to 3.11 0.07, 3.34 0.11, 3.15
0.09, and 3.06 0.08 by IPC, IPC and 45-min Isc, CPC and 45-min Isc, respec-
tively (p<0.01). Immunoblots of membrane PKC were increased by IPC, IPC
and 45-min Isc, and CPC. These effects were abolished by PKC inhibition. Thus,
activation of PKC may have trigger role in the mechanism of cardioprotective
effect by CPC.
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Experimental protocol
Experimental protocols are shown in Fig. 1. After commenc-
ing retrograde aortic perfusion, hearts were allowed to stabi-
lize for 50 min, and baseline hemodynamics were measured.
Coronary flow was measured by timed collection of coronary
venous effluent as previously described (5). The hearts were
randomly assigned to the following experimental groups: 1)
in the non-preconditioned ischemic control (n=7), hearts were
subjected to 45-min global ischemia followed by 120-min
reperfusion; 2) in the ischemic preconditioning (IPC) group
(n=8), hearts were preconditioned with 5-min global ischemia
followed by 10-min reperfusion, and then subjected to 45-
min global ischemia and 120-min reperfusion; 3) in the Ca2+
preconditioning (CPC) group (n=10), hearts were precondi-
tioned with 5-min Ca2+-free perfusion followed by 10-min
perfusion with Tyrode solution (containing 1.0 mmol/L CaCl2),
and then subjected to 45-min global ischemia and 120-min
reperfusion; 4) in the CPC and PKC inhibitor-treated (CPC
PKCi) group (n=8), the experimental method was as similar
as in the CPC group, except calphostin C (200 nmol/L) was
given for 10 min during CPC regimen. We did not determine
the effect of calphostin C in the non-preconditioned heart in
which 45-min ischemia was given as in this study, since 200
nmol/L of calphostin C did not affect post-ischemic functional
and biochemical data in those hearts of our previous study (20).
To determine the changes of PKC activity, supplement ex-
periments (n=5 each) were added: experiments stopped just
after baseline stabilization (base), 45-min global ischemia (Isc),
IPC regimen (IPC), IPC regimen and 45-min global ischemia
(IPC Isc), CPC regimen (CPC), CPC regimen and 45-min
global ischemia (CPC Isc), CPC regimen and PKCi treat-
ment (CPC PKCi) and CPC regimen, PKCi treatment and
45-min global ischemia (CPC PKCi Isc). All heart speci-
mens were frozen in liquid nitrogen and stored at -80 before
biochemical and molecular assays.
Any heart without established baseline for prolonged per-
fusion for more than 50 min with poor contractility and per-
sistent arrhythmia (ventricular tachycardia or fibrillation per-
sisting for more than 20 min) on initial perfusion or reperfu-
sion were excluded from the further study.
Determination of infarct size and lactate dehydroge-
nase (LDH) leakage
Infarct area was determined by the method previously de-
scribed (5). In brief, after the experiment, the heart was per-
fused with 1% triphenyltetrazolium chloride (in phosphate
buffer) for 20 min at room temperature and immersed over-
night in 10% neutral formalin. Heart slices were photographed
and the infarct area was determined by computerized mor-
phometry.
LDH leakage was determined by the measurement of its
activity in the timely collected coronary effluent with a diag-
nostic kit (Sigma).
PKC assay and Western blot analysis of PKC
isozymes
The left ventricle including interventricular septum was
homogenized in 3 vols of buffer solution (containing in mmol/
L: Tris-HCl 20.0, sucrose 250.0, iodoacetic acid 1.0, phenyl-
methylsulfonyl fluoride 1.0, EDTA 1.0, EGTA 1.0, and  -
mercaptoethanol 10.0; pH 7.4 at 4 ) using Ultra-Turrax
homogenizer (10,000 rpm, 3 times for 30 sec each). Crude
homogenate was centrifuged (360 g at 4 for 10 min). The
supernatant was centrifuged at 100,000 gat 4 for 1 hr and
the resulting supernatant was used for the measurement of
cytosol PKC activity. Pellet was resuspended in 2 vols of the
same buffer containing 0.3 vol% of Triton X-100 and gen-
tly stirred at 4 for 1 hr, centrifuged at 100,000 g for 1 hr,
and the resulting supernatant was used for measurement of
membrane PKC activity. PKC activity was determined by
using a commercial kit (PKC Assay System, RPN 77A, Amer-
sham) as previously described (22, 23), and the protein con-
centration in each fraction was determined by using DC Pro-
tein Assay (Bio-Rad).
Cytosol and membrane PKC samples (each sample contain-
ing 50  g of protein) were processed by SDS-PAGE (7.5%
separating gel) at 25 mA constant current for 5 hrs. Bio-Rad
Kaleidoscope prestained standards were used to determine
molecular masses. Proteins were transferred from gels to PVDF
membrane (Hoefer Scientific). The PVDF membrane was in-
cubated in blocking buffer (pH 7.6) containing 5% skim milk,
25 mmol Tris-HCl, 100 mmol NaCl and 0.1% Tween 20 for
1 hr at room temperature, and then incubated for 1 hr at room
temperature with primary monoclonal antibodies ( ,  ,  ,  ,
and  , Transduction Laboratory) at indicated concentrations
(1:1,000). After intensive washing with 5% skim milk-free
blocking buffer, blots were incubated for 1 hr in buffer con-
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Fig. 1. Schematic illustration of the experimental protocol. Hearts
were subjected to 5-min global ischemia and 10-min reperfusion in
the ischemic preconditioned (IPC) group and to 5-min Ca
2+-deple-
tion and 10-min repletion in the Ca
2+-preconditioned (CPC) group,
before 45-min ischemia. In the CPC+PKCi (PKC inhibitor) group,
calphostin C (CalC) was given for 10 min and washed out for 5 min
during CPC. B, baseline. TTC: triphenyltetrazolium.Ca
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taining goat anti-mouse peroxidase conjugate (1:1,000, Bio-
Rad). Finally, immunoreactive bands were visualized by en-
hanced chemiluminiscence method (Amersham).
Statistics
Data were presented as mean SEM; they were analyzed
by paired t-test within the same experimental group and by
one-way ANOVA for repeated measures within different ex-
perimental groups. When significant differences were obse-
rved, the mean values were evaluated with Tukeys post-hoc
test. A pvalue less than 0.05 was considered significant.
RESULTS
Functional parameters
The baseline values of LVDP,  dP/dt, LVEDP and coro-
nary flow were not different between experimental groups.
Ischemia caused a rapid drop in LVDP,  dP/dt and coronary
flow; these parameters stayed at zero point during ischemia
for 45-min. On reperfusion, IPC enhanced LVDP and  dP/
dt recovery, but CPC did not. LVDP and dP/dt recovery on
reperfusion were greater in the IPC group (>90% of pre-
ischemic value) than in the ischemic control group (<70% of
preischemic value), however, these parameters in the CPC and
CPC PKCi groups were less than 50% of preischemic values
(Fig. 2). Coronary flow recovery in the IPC group was greater
than in the ischemic control group. It reached near to pre-
ischemic value and maintained approximately at >90% of
preischemic value in the IPC group, but difference between
the IPC and ischemic control groups (80-90% of preischemic
value) was not evident. In contrast, CPC and CPC+PKCi
depressed the coronary flow recovery. Coronary flow recovery
was smaller in the CPC group (<60% of preischemic value)
than that in the ischemic control group (Fig. 2), but the dif-
ference was not evident between the CPC and CPC PKCi
groups. In all experimental groups, LVEDP was increased by
35 min after ischemia and further increased immediately after
the onset of reperfusion. The increased levels of LVEDP last-
ed throughout reperfusion both in the ischemic control and
IPC group, however, the increase was less prominent in the
IPC group (p<0.05). This result means that IPC attenuated
myocardial contracture during reperfusion. In the CPC group,
LVEDP reached a plateau (>100 mmHg, p<0.01 vs ischemic
control group) in the earlier period of reperfusion and pro-
gressively decreased afterwards (approximately 50 mmHg
at the end of reperfusion).
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Fig. 2. Changes of the recovery rate of left ventricular developed pressure (LVDP), contractility (+dP/dt), left ventricular end-diastolic pres-
sure (LVEDP), and coronary flow during ischemia and reperfusion. *p<0.05, **p<0.01, ischemic control vs. IPC; 
#p<0.05, CPC+PKCi vs.
CPC;  p<0.05, ischemic control vs. CPC+PKCi.
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Infarct size (Fig. 3, 4) was expressed as a percentage of the
left ventricle including the interventricular septum. We did
not assume risk area since the entire myocardium might be
at risk in global ischemia. Compared with the ischemic con-
trol (45.2 2.4%), the infarct size was reduced by IPC (21.0
1.3%, p<0.05) and CPC (25.5 2.2%, p<0.05); however,
infarct size was not reduced or limited by PKCi treatment
(CPC PKCi, 37.9 2.5%).
LDH leakage at the baseline in the coronary effluent of the
ischemic control, IPC, CPC, and CPC PKCi groups were
6.00 0.62, 5.29 0.50, 5.50 0.54, 5.81 0.60 unit/mL,
respectively. It was significantly increased in the ischemic
control and CPC PKCi groups on reperfusion (p<0.05 vs
CPC group, 5-20 min), however, no significant difference was
found between the IPC and CPC groups (Fig. 5).
PKC activity and Western blot analysis of PKC
isozymes 
Total PKC activity in the baseline, after 45-min ischemia,
IPC, IPC and 45-min ischemia, CPC, CPC and 45-min isch-
emia, CPC PKCi, and CPC PKCi and 45-min ischemia
were 8.57 0.06, 8.31 0.04, 8.75 0.12, 8.81 0.10,
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Fig. 3. Heart slices stained with triphenyltetrazolium chloride (TTC).
Infarct (white area) was limited by IPC and CPC but infarct size-lim-
iting effect is abolished by PKC inhibition with calphostin C (CPC
+PKCi).
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Fig. 4. Infarct size as percentage of the left ventricle. Infarct size
was reduced by IPC and CPC but reduction of infarct size is ab-
olished by PKC inhibition with calphostin C (CPC+PKCi). *p<0.05,
vs. ischemic control. 
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Fig. 5. Lactate dehydrogenase (LDH) leakage in the coronary efflu-
ent. During early period on reperfusion, LDH leakage is signifi-
cantly increased in the ischemic control and CPC+PKCi. B, base-
line. *p<0.05, vs. CPC+PKCi.
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Fig. 6. Protein kinase C (PKC) activity. PKC activities of the cytosol
fractions are not significantly different between the experimental
groups; however, those of the membrane fractions increase by
ischemic preconditioning (IPC), IPC and 45-min ischemia (IPC+
45-min Isc), Ca
2+ preconditioning (CPC), and CPC and 45-min
ischemia (CPC+45-min Isc). *p<0.01, vs. baseline.
* * * *8.68 0.14, 8.76 0.06, 8.61 0.05, 8.52 0.12 nmol/g
tissue, respectively. It was slightly increased after the IPC and
CPC regimen, however, there was no significant difference. As
shown in the Fig. 6, cytosol PKC activity was not different
between groups and membrane PKC activity was not changed
after 45-min ischemia, CPC PKCi, and CPC PKCi and
45-min ischemia; however, membrane PKC activity was sig-
nificantly increased after IPC, IPC and 45-min ischemia,
CPC, and CPC and 45-min ischemia (p<0.01), from 2.53
0.07 nmol/g tissue (baseline) to 3.11 0.07 (IPC), 3.34
0.11 (IPC 45-min Isc), 3.15 0.09 (CPC), and 3.06
0.08 nmol/ g tissue (CPC 45-min Isc). These results indi-
cate that PKC was activated and translocated from the cytosol
to the cell membrane by IPC or CPC.
Five PKC isozymes ( ,  ,  ,  , and  ) were analyzed by We-
stern blot with corresponding monoclonal antibodies against
each isozymes. Distribution and intensity of PKC isozymes
except PKC were not different between experimental groups
(data not shown). In comparison with the baseline, the mem-
brane fraction of PKC increased after IPC, IPC and 45-min
ischemia, and CPC (Fig. 7).
DISCUSSION
As already established, the myocardial cell uses Ca2+ as the
essential final step in excitation-contraction coupling, the pro-
cess by which depolarization of the cell surface membrane ini-
tiates the interactions between the contractile proteins that
lead to tension development and shortening in the wall of the
heart. Ca2+ also mediates stimulus-secretion coupling in a vari-
ety of non-motile cells. As indicated, Ca2+ ions, by carrying
signals generated at the cell surface to a variety of intracellu-
lar organelles and proteins, can be viewed as the most impor-
tant of the intracellular messengers (24). It is generally believed
that a high Ca2+ influx during ischemia/reperfusion (Ca2+ over-
load) causes pathological changes in the ischemia/reperfusion
injury; however, in a rat heart, Ashraf et al. (17) have demon-
strated that repetitive Ca2+ depletion and repletion for a short
duration (Ca2+ preconditioning, CPC) had induced a signifi-
cant functional recovery and remarkable preservation of cell
structure against ischemia/reperfusion injury. Our results are
partly consistent with Ashraf et al. (17). However, functional
recovery by CPC was not seen, although infarct size was sig-
nificantly reduced by IPC and CPC; LVDP and dP/dt recov-
ered only 25-30% of the baseline values, compared with those
in the IPC group (80-90% of baseline values) or even in the
ischemic control group (60-70% of baseline values). The rea-
son of depressed functional recovery by CPC in this study is
unclear. Differences in species and experimental methods could
be causing factors, but they are not satisfactory explanations.
Since the early increase of LVEDP on reperfusion after 45-min
ischemia in the CPC group was evident, it was doubtful whe-
ther the CPC regimen in this study would cause Ca2+ paradox
injury, in which necrosis of the cell is a common feature, or not.
However, functional parameters after Ca2+ depletion and reple-
tion in the CPC group were not significantly different from the
baseline values, and LDH leakage was not different between
the IPC and CPC groups after 45-min ischemia. Moreover,
infarct size was reduced or limited by CPC as seen in the IPC
group. From these results, it could be concluded that 5-min Ca2+
depletion and 10-min Ca2+ repletion did not cause Ca2+ para-
dox injury. Reduced response or sensitivity of contractile pro-
teins to normal Ca2+ concentration or reduced energy produc-
tion on reperfusion due to myocardial stunning by CPC could
be another possible factor, although intracellular Ca2+ and ener-
gy metabolism were not considered. They can cause a retarded
functional recovery with diastolic abnormalities.
The physiological function of protein kinases is not yet fully
understood, but PKC is activated upon external stimulation
of the myocyte by various ligands including hormones, neuro-
transmitters, and growth factors. Many lines of evidence in-
dicate that PKC is involved in IPC of the heart. In this study,
membrane PKC activity was increased by IPC and CPC, while
PKC inhibition did not increase the activity. These results
indicate that PKC was activated by IPC and CPC, and translo-
cated from the cytosol to the cell membrane. It has been sug-
gested that the elevation of  Ca2+ i during IPC, in part, result-
ed from Ca2+ entry via voltage-dependent Ca2+ channel (8, 25)
triggers activation of PKC. However, cytosol PKC was not
significantly decreased in both IPC and CPC in this study as
in a rat heart (19), in contrast to other studies (8, 26). The
reason for this is unclear, however, there is a possibility that
a small change in the cytosol PKC by CPC or IPC did not
affect the total amount of cytosol PKC, since the amount of
cytosol PKC is much greater than that of membrane PKC.
In addition, in this study, immunoblots of the membrane
PKC were evidently increased by IPC, IPC and 45-min is-
chemia and by CPC, while concurrent PKC inhibition abol-
ished the increase of membrane PKC . These results strong-
ly suggest that the activation of membrane PKC is closely
related with the infarct size-limiting effects of IPC and CPC.
There are some evidences that specific PKC isozymes were
responsible for the mechanism of IPC or CPC. Ping et al. (27)
described that IPC caused selective translocation of PKC and
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Fig. 7. Western blot analyses of PKC . Membrane (Memb) PKC
is increased by IPC, IPC and 45-min ischemia (IPC+45-min Isc),
and by CPC, while cytosol fraction between groups is not signifi-
cantly different. Base, baseline; PKCi, PKC inhibition with cal-
phostin C.PKC without demonstrable changes in total myocardial
PKC activity in the conscious rabbit heart, and our previous
study (20) demonstrated that PKC has a trigger role for
cardioprotective effect of IPC in the isolated rabbit heart. In
contrast, Miyawaki et al. (19) demonstrated that immunolo-
calization of PKC and PKC increased in the cell membrane
of rat hearts. However, there is a controversy over the differ-
ent PKC-coupled receptor systems, which might be involved
in IPC. PKC activator did not reduce infarct size in canine
hearts (22), and in porcine hearts, even the infarct size reduced
by PKC inhibitor (28). These inconsistent results might have
been derived from the following possibilities: 1) activation of
PKC was not sufficient to phosphorylate certain key proteins;
2) expression of specific PKC isozymes was not significant to
participate in the protection; or 3) mechanical factors of IPC
or CPC protocol itself caused an aggravation of myocardial
stunning. These experimental data provide that the activation
of PKC may not be an universally applicable mechanism for
the cardioprotective effect of IPC or CPC in common labora-
tory animals, however, from this study, it is conceivable that
a single dose of CPC could not enhance functional recovery but
could protect the heart from infarction. Activation of mem-
brane PKC may be responsible for trigger role in the car-
dioprotection by both IPC and CPC.
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